NUS Academy for Healthy Longevity

What NUS Academy for Healthy Longevity does

The NUS Academy for Healthy Longevity is an academic unit within the National University of Singapore that operates in the emerging field of precision geromedicine. It pursues a paradigm shift away from treating individual age-related diseases toward targeting the biology of aging itself through education, clinical research, and clinical translation. The Academy is led by Co-Founder and Director Prof. Andrea B. Maier (490+ peer-reviewed publications, WHO advisor) and Co-Founder Prof. J.J. (Hans) Meij, supported by a team of 25+ faculty, research fellows, PhD students, and visiting scholars. Its work spans epigenetic clock research, biological age biomarkers, supplement and drug interventions, AI-guided dosing, and lifestyle protocols.

The Academy's product surface is split between education and clinical research. Education programs include the 12-day Healthy Longevity Talent Incubator (HLTI) for Master's/PhD students and early-career professionals (tiered fees SGD 550–2,050), the 3-day Intensive Course on Healthy Longevity for mid-career professionals (SGD 3,500 with CME accreditation), 4-hour specialized workshops (SGD 450), and customized organizational training. Clinical research includes multiple parallel trials — CEDIRA (400-participant multivitamin/DNA methylation study), SIRT6 (Fucoidan in adults 50–80), ACCURATE (CURATE.AI-guided NMN dosing), PROMETHEUS (precision geromedicine for XPRIZE Healthspan), Rejuvenating Microbiome Study (with Danone Asia Pacific), and Wellcome Leap (AKG in 250 older adults post-CABG). Supporting initiatives include the Global Epigenetic Age Consortium, HELO international survey across eight countries, HEAL clinic evaluation at Alexandra Hospital, and the RESORT geriatric cohort.

The Academy's revenue model is academic rather than commercial: course fees (one-time, tiered), research grants and donations (via NUS giving pages including the HLTI Grant and Academy Impact Fund), and industry-funded clinical trial partnerships. Go-to-market is event-driven and community-led — intensive courses, conferences, Open Days, and the HLTI Alumni Group drive demand generation across Asia-Pacific, Europe, and North America. The entity is part of the public NUS system and does not appear to carry external venture or private equity investment.

Name

NUS Academy for Healthy Longevity

Legal name

NUS Academy for Healthy Longevity

Website

https://longevityacademy.sg

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

NUS Academy for Healthy Longevity is a Singapore-based academic unit within the National University of Singapore conducting precision geromedicine research, clinical trials on aging interventions, and educational programs including a 12-day talent incubator and intensive courses for healthcare professionals and students.

Ownership category

akta.pro rank

Product category

Longevity Education and Clinical Research

NAICS

Colleges, Universities, and Professional Schools (61131), All Other Schools and Instruction (61169), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

akta.pro industry

PRIMARYEDAAAMAG

Health, Wellness & Healthy Aging Education (Chronic disease, mobility, nutrition)

Education/Adult & Continuing Education/Adult Learning for Seniors (Third Age / Lifelong Learning Institutes)

SECONDARYEDAAAMAA

Lifelong Learning Institutes (Osher/OLLI-style) & Senior Academies

Education/Adult & Continuing Education/Adult Learning for Seniors (Third Age / Lifelong Learning Institutes)

SECONDARYEDAAAMAC

University- or College-Affiliated Senior Learning Programs

Education/Adult & Continuing Education/Adult Learning for Seniors (Third Age / Lifelong Learning Institutes)

SECONDARYHSADAGAK

Healthy Aging & Longevity Lifestyle Coaching

Home & Personal Services/Fitness, Wellness & Personal Training/Health Coaching & Lifestyle Wellness

Keywords

• Precision geromedicine
• Healthy longevity education
• Clinical aging research
• Geroscience training
• Biological age studies

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Education Course Fees: Revenue from intensive courses, workshops, and talent incubator programs. Fees range from SGD 450 for standalone workshops to SGD 3,500 for intensive courses, with tiered pricing for the talent incubator based on participant status.
2. Research Grants and Donations: Funding from donors and grant programs to support education accessibility and research operations. The Academy accepts donations for education initiatives and the Academy Impact Fund.
3. Clinical Trial Partnerships: Industry-funded clinical research with partners such as Danone Asia Pacific for studies on supplements, nutrition, and lifestyle interventions in healthy longevity.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

The Academy provides education programs (Healthy Longevity Talent Incubator, Intensive Course, Customised Courses) and conducts clinical trials and research studies in precision geromedicine. It targets aging itself rather than age-related diseases through DNA methylation analysis, multi-omics approaches, and intervention studies evaluating supplements, nutraceuticals, lifestyle programs, and AI-guided dosing strategies.

Product overview

NUS Academy for Healthy Longevity offers a comprehensive portfolio combining education programs and clinical research in precision geromedicine. Education offerings include the 12-day Healthy Longevity Talent Incubator (HLTI) for next-generation leaders, the 3-day Intensive Course for mid-career professionals, and customized corporate training programs. The Academy conducts extensive clinical research including trials on multivitamin supplementation (CEDIRA), SIRT6 modulation (SIRT6 Study), AI-guided NMN dosing (ACCURATE), precision lifestyle interventions (PROMHEUS contributing to XPRIZE Healthspan), and microbiome rejuvenation. Additional research initiatives include the Global Epigenetic Age Consortium for epigenetic clock research, the HELO international survey on healthy longevity perspectives, the HEAL clinic evaluation study, the RESORT geriatric cohort study, and the Wellcome Leap study on surgical recovery. Public engagement includes Open Days and the annual Unlock Healthy Longevity Conference, supported by a Clinical Alliance network for healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

• HLTI: Healthy Longevity Talent Incubator - A passion project to expand the pool of future leaders in GeroScience and Healthy Longevity Medicine, offering subsidized program fees.
• CEDIRA
• PROMETHEUS
• SIRT6 Study
• ACCURATE
• Rejuvenating the Microbiome
• HELO
• HEAL
• Wellcome Leap Study
• Global Epigenetic Age Consortium

Products and services

• Healthy Longevity Talent Incubator (HLTI) A 12-day intensive residential program designed for Master's and PhD students and early-career professionals to develop next-generation leaders in geroscience and healthy longevity medicine. The program includes mentorship, networking with pioneers, and hands-on training at NUS Campus. Up to 40 participants are selected annually with tiered subsidized fees (SGD 2,050 full fee; SGD 1,025 partial fee for research fellows/early-career professionals; SGD 550 for Master's/PhD students).
• Intensive Course on Healthy Longevity A 3-day immersive course on NUS Campus for mid-career healthcare professionals offering deep conversations with leading academics and entrepreneurs in the healthy longevity field. The course is scheduled for 23-25 February 2026 and 22-24 February 2027. Includes Certificate of Attendance, 12 CME points, and is capped at 80 participants. Fee is SGD 3,500 (inclusive of GST).
• Customised Courses Tailored training programs provided upon request by expert tutors for organizations seeking to upskill their teams in healthy longevity topics. Courses are customized to specific organizational needs and objectives, delivered through contact-based inquiry.
• CEDIRA Clinical Trial A 12-month double-blind, placebo-controlled clinical trial investigating effects of daily multivitamin and mineral supplementation on biological age in 400 middle-aged participants aged 40-60. Biological age is measured through DNA methylation analysis.
• SIRT6 Study A clinical study exploring how modulating SIRT6 enzyme pathways with seaweed-derived Fucoidan supplementation can influence biological ageing and improve overall health in adults aged 50-80. Involves detailed assessments of biological age, metabolic health, and cognition over 6 months. Participants receive SGD 30 reimbursement per visit and free health screening.
• ACCURATE Study A research study evaluating how effective CURATE.AI, an artificial intelligence-guided dosing method, is compared to standard dosing in improving blood levels of NAD using nicotinamide mononucleotide (NMN) for participants aged 35-65.
• PROMETHEUS Study An 8-week single-arm feasibility study testing a precision geromedicine intervention for adults aged 50-80, involving multimodal program of sleep/dietary guidance, supervised exercise with exergaming, motivational coaching, and supplementation. Study contributes to the XPRIZE Healthspan competition.
• Rejuvenating Microbiome Study A 12-week interventional study evaluating combined effects of synbiotic-enriched multi-nutrient supplement and supervised exercise on gut health, muscle function, immunity, cognition, and biological ageing in pre-frail adults aged 50-80. Conducted in partnership with Danone Asia Pacific. Participants receive SGD 50 per visit for transportation (up to SGD 200 total).
• Wellcome Leap Study A double-blind placebo-controlled clinical trial evaluating the impact of Alpha-Ketoglutarate (AKG) in reducing morbidity and improving patient-centred outcomes after coronary artery bypass grafting surgery in 250 older adults at Singapore's National University Hospital and National Heart Centre.
• HELO (HEalthy LOngevity) Survey An international consortium investigating public perspectives on lifespan, healthspan, and healthy longevity, surveying populations across multiple countries including Singapore, Indonesia, Netherlands, Switzerland, Hungary, USA, UAE, and Thailand.
• HEAL (Health Enhancing Active Living) Study A longitudinal observational study evaluating the efficacy and real-world effectiveness of the Healthy Longevity Clinic at Alexandra Hospital, assessing the shift from traditional 'sick care' to preventive healthcare.
• RESORT Cohort Study A cohort study evaluating the Comprehensive Geriatric Assessment (CGA) approach in optimizing care for geriatric inpatients, examining post-discharge outcomes including quality of life, independence, hospital readmissions, and survival. Conducted between October 2017 and March 2020 with 1,890 geriatric inpatients.
• Global Epigenetic Age Consortium An international consortium dedicated to summarizing evidence, interpreting clinical relevance, and advancing clinical translation of epigenetic clocks as tools for precision medicine research and practice. Includes systematic reviews and meta-analyses, with 50+ researchers across multiple institutions.

Quantifiable outcome

• Published landmark study: Biological age measured by DNA methylation clocks and frailty: a systematic review and meta-analysis in The Lancet Healthy Longevity
• +3 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• Danone Asia Pacific Holdings Pte LtdcoreStrategic or Co-development PartnerIndustry partner for the Rejuvenating Microbiome Study, which evaluates combined effects of synbiotic-enriched multi-nutrient supplement and supervised exercise on gut health, muscle function, immunity, cognition, and biological ageing in pre-frail adults. Danone provides the research-grade powder supplement containing protein, omega-3, vitamin D, and synbiotics (GOS, FOS, pectin, Bifidobacterium longum BB536).
• Healthy Longevity Medicine SocietycoreStrategic or Co-development PartnerGlobal network partner collaborating with the Global Epigenetic Age Consortium. The partnership leverages collective expertise and resources to accelerate evaluation efforts and provide robust evidence supporting the use of epigenetic clocks.
• Biomarkers of Aging ConsortiumcoreStrategic or Co-development PartnerCollaborative consortium contributing to the Global Epigenetic Age Consortium's mission to bridge the gap between research and clinical application of epigenetic clocks in precision medicine.
• XPRIZE Foundation (Healthspan Competition)coreStrategic or Co-development PartnerPROMETHEUS study results will guide a 12-month trial for the XPRIZE Healthspan competition, combining lifestyle, nutraceutical, and repurposed drug strategies to slow aging. The study is designed to contribute actionable outcomes for the global competition.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Others

• Longevity.Technology: A media, market intelligence, and event company covering the longevity industry with a focus on connecting researchers, investors, and entrepreneurs. Comparable as a longevity ecosystem participant that has featured the Academy in its coverage and co-organizes events like Founders Longevity Forum Singapore.

Emerging players

• Insilico Medicine: An AI-driven drug discovery company with a significant focus on aging and longevity, combining computational biology with clinical development. Comparable in targeting aging biology with novel methodologies (parallel to the Academy's use of CURATE.AI for NMN dosing), though operating as a commercial biotech.
• SENS Research Foundation: A non-profit research organization focused on developing rejuvenation biotechnologies to treat aging as a medical condition. Comparable in mission to "target aging itself" and in combining research with public education/advocacy, though more focused on fundamental biology rather than clinical translation.
• Altos Labs: A well-capitalized biotech company founded in 2022 pursuing cellular rejuvenation programming to treat aging and age-related diseases. Comparable in pursuing the paradigm shift from treating age-related diseases to targeting aging biology, though as a commercial venture with significantly greater funding than the Academy's donor-supported model.

Direct peers

• Buck Institute for Research on Aging: The world's first biomedical research institute singularly focused on aging, conducting basic research and training the next generation of scientists in geroscience. Directly comparable to the Academy as a non-university-based research and education organization dedicated to understanding and targeting aging biology.
• Duke-NUS Medical School - Centre for Ageing Research and Education: Singapore-based academic center focused on aging research, education, and policy. Directly comparable as a Singapore-based academic institution with overlapping mission in longevity research, clinical training, and policy engagement; also visible in the Academy's team history.
• Albert Einstein College of Medicine - Institute for Aging Research: One of the most prominent US academic centers for aging research, focusing on the biology of aging, longevity genes, and clinical translation. Comparable as a university-affiliated institute combining basic geroscience research with clinical studies and training programs for healthcare professionals.

Broad incumbents

• Karolinska Institutet - Aging Research Center: A leading European academic center conducting epidemiological and clinical aging research with strong educational programs. Comparable as a university-affiliated center combining population-level longevity research, clinical studies, and graduate training in aging science.
• Mayo Clinic - Robert and Arlene Kogod Center on Aging: Mayo Clinic's Kogod Center on Aging conducts translational aging research and trains clinicians in geriatric medicine, with a broader portfolio spanning many medical specialties. Comparable in combining aging research with clinician education and clinical trials, but at much larger scale and as part of a major US healthcare system.
• Harvard Medical School - Division of Aging: Harvard's aging research portfolio spans multiple labs and centers including the Division on Aging, with deep integration into medical education and clinical training. Comparable as a university-based program that trains clinicians and researchers in geroscience, but with significantly broader institutional resources and global brand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/nus_longevity
• LinkedInlinkedin.com/company/longevityacademysg
• Instagraminstagram.com/nus_longevity

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NUS Academy for Healthy Longevity